Pharmaceutical Focus
Research and Development
Prophylactic and Therapeutic Vaccines
A novel approach for treatment of cancer
Cancer immunotherapy, including the development of prophylactic and therapeutic vaccines, is considered a novel approach for prevention and treatment of cancer.
Pharma Articles
Increasing speed to market through R&D Stage Gate.
Dr Ankasha Tejam and Frank VivinoManagement Consulting Services Infosys Limited
As many as four out of ten drugs identified as potential lead candidates during lead optimization stage, fail in late stage of clinical trials. Failures of these late stage leads are one of the primary causes for the shrinking drug pipeline resulting in higher cost pressures due to waste of significant capital investment right at early stage Research.
TechnoTrends
New Technology to Monitor Crystal Formation
Researchers at the University of Leeds have come up with a technology that could help the pharmaceutical industry in controlling crystal formation during the process of drug development.
Pharmaceuticals often come in the crystalline forms and undetected fluctuations in the system can alter the crystal structure which is not desired by the pharmaceutical manufacturers. ...
Interview
GE Healthcare expands its life sciences business
Peter Ehrenheim,
President & CEO, Life Sciences, GE Healthcare
"Our current business focus and strengths are in the areas of bioprocessing, proteins, cellular analysis, cell handling and tools for cell therapy. Our strategic intent is to add adjacent technologies or applications which can add value to the overall customer solutions we provide. "
Pharma Projects
Beike Biotech to open Jiangsu stem cell storage facility in China
Shenzhen Beike Biotechnology Co., Ltd announced that it has commenced the construction of a medical stem cell facility in the China for the storage and processing of human stem cell samples for clinical applications.
Articles
Increasing speed to market through R&D Stage Gate.
Dr Ankasha Tejam and Frank VivinoManagement Consulting Services Infosys Limited
As many as four out of ten drugs identified as potential lead candidates during lead optimization stage, fail in late stage of clinical trials. Failures of these late stage leads are one of the primary causes for the shrinking drug pipeline resulting in higher cost pressures due to waste of significant capital investment right at early stage Research.
Overcoming Regulatory Barriers
To Fast-Track Clinical Trials
Perhaps the most significant factor is population size. The populations of the countries in Asia represent a huge patient pool, much of which is located in urban areas and close to sites and investigators involved in global studies.
e-Book | Issue 14, 2011
Get instant acces to the e-Book version of the latest magazine
Pharma News
16 May, 2012
Immune Deficiency Foundation Urges FDA To Exempt I ...
16 May, 2012
SCS is First U.S. Certification Body Recognized un ...
16 May, 2012
Pharma Events
May 1 - May 3 2012
Indo Medicare 2012...
May 3 - May 6 2012
US-China Pharma...
May 9 - May 10 2012
Knowledge Bank
Interviews
Peter Ehrenheim, President & CEO, Life Sciences, GE Healthcare "Our current business focus and strengths are in the areas of bioprocessing, proteins, cellular analysis.. "
Articles
Dr Ankasha Tejam and Frank Vivino Management Consulting Services Infosys Limited
Techno Trends
Researchers at the Massachusetts Institute of Technology have come up with the first fully synthetic nanoparticles capable of cell penetration without rupturing the same.
Research Insights
The United States (US) Food and Drug Administration (FDA) approves new drugs based on sponsor-submitted clinical trials.
Projects
- Multiple Expansion Plans For Bangladesh's Pharmaceutical Industry
The three leading pharmaceutical companies of Bangladesh, Acme Laboratories, Square Pharmaceuticals and Advanced Chemical Industries...
Industry Reports
A report by CurrentPartnering A Report by PricewaterhouseCoopers Welcome to the Option Agreements in Pharma and Biotech report.
Case Studies
Marcus N. Allhands, PhD, PE Water chemistry is routinely addressed in cooling systems. Scale formation, corrosion and biological growth are just some of the activities that can be abated by proper use of chemical additives
White Papers
By Tim Freeman, Freeman Technology
Wet granulation is a common unit operation in the pharmaceutical industry yet accurate endpoint detection remains a challenge.
Strategy
Metabolic Biomarker and Target Discovery in Obesity-Associated Comorbidities
Millions of adults are diagnosed as obese each year. Many of these people are at risk of developing additional diseases..
Clinical Trials
Mobile Phones"Always There Always On
President & CEO, Life Sciences, GE Healthcare "Our current business focus and strengths are in the areas of bioprocessing, proteins, cellular analysis.
Manufacturing
Similar Biologics
A golden bird to tame
Biologics are inherently different from chemicals drugs in terms of their source, structural complexity, fragility of the active substance..
Information Technology
Emerging Trends in Functional Service Outsourcing
The IT outsourcing industry has laid down a solid foundation in terms of establishing and providing service and pricing model that can be ramped up...
Research & Development
Prophylactic and Therapeutic Vaccines
Cancer immunotherapy, including the development of prophylactic and therapeutic vaccines..
Expert Talk
Industry-Academia Interactions
In the Indian scenario, teachers are overburdened and are involved in too many non-academic activities resulting in poor research output.
Testimonials
I have been very impressed with the quality and timeliness of the articles. Each of the authors has done an excellent job of reviewing their topics. The issue has become a "keeper" for me on that basis alone. Bravo on a job well done by all.
David R. Webb, Vice President, Research, Signal Pharmaceuticals, LLC, A wholly owned subsidiary of CELGENE, USA.
© 2004-2012 Ochre Media. All rights reserved. 